COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Muscle Fatigue and Foot Biomechanics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03607253
Recruitment Status : Completed
First Posted : July 31, 2018
Last Update Posted : November 14, 2018
Sponsor:
Information provided by (Responsible Party):
Halit SELÇUK, Trakya University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Medial longitudinal arch (MLA) is a curve of the foot located at the medial side of the body and protection of the height of the MLA is an important factor for limb health.

This study was planned with the aim of investigating the response of the MLA height to the repetitive muscle activity and determine the gender-related differences.


Condition or disease Intervention/treatment Phase
Foot, Flat Other: repetitive heel rise activity Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Other
Official Title: Investigating the Gender-related Response of Muscle Fatigue of the Medial Longitudinal Arch Height in Healthy Young
Actual Study Start Date : September 30, 2018
Actual Primary Completion Date : October 15, 2018
Actual Study Completion Date : October 30, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fatigue Foot Health

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Men
Healthy young men aged between 18-25 years
 Other: repetitive heel rise activity
Participants will perform a maximal number of single-legged heel rises on a 10 degrees incline board. Participants will be permitted to apply for fingertip support at shoulder height on a wall in front of them. The test will be terminated when participants could no longer lift their heels from the incline board. The number of correct heel rises will be counted for each leg and will be used as Heel Rise Test score.
Women
Healthy young women aged between 18-25 years
 Other: repetitive heel rise activity
Participants will perform a maximal number of single-legged heel rises on a 10 degrees incline board. Participants will be permitted to apply for fingertip support at shoulder height on a wall in front of them. The test will be terminated when participants could no longer lift their heels from the incline board. The number of correct heel rises will be counted for each leg and will be used as Heel Rise Test score.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Navicular Drop [ Time Frame: at first minute, change from baseline arch height at 2nd minutes ]
    Vertical distance of navicular tuberosity (highest point of the MLA) to the ground is measured for two times. First; with the foot placed in subtalar joint neutral position in full weight-bearing and second; in relaxed standing position. The difference between the two values are recorded as Navicular Drop (mm).


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Gender Eligibility Description:   females and males
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy young females and males who want to participate to the study

Exclusion Criteria:

  • have orthopedic, physiologic, psychiatric, neurologic or systemic disorders
  • have present medication
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03607253


Locations
Layout table for location information
Turkey
Trakya University
Edirne, Turkey, 22000
Sponsors and Collaborators
Trakya University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Halit SELÇUK, Principal Investigator, Trakya University
ClinicalTrials.gov Identifier: NCT03607253    
Other Study ID Numbers: TUTF-BAEK 2018/159
First Posted: July 31, 2018    Key Record Dates
Last Update Posted: November 14, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Halit SELÇUK, Trakya University:
medial longitudinal arch
foot
Additional relevant MeSH terms:
Layout table for MeSH terms
Flatfoot
Fatigue
Talipes
Foot Deformities, Acquired
Foot Deformities
Musculoskeletal Diseases
 Foot Deformities, Congenital
Lower Extremity Deformities, Congenital
Limb Deformities, Congenital
Musculoskeletal Abnormalities
Congenital Abnormalities